Spectris plc: Director/PDMR Shareholding
This notification is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
On 21 February 2020, Spectris plc ("the Company") was notified by Cathy Turner, Non-executive Director, that she had today acquired 2,342 ordinary shares at a price of 2,988.0 pence per share.
The form required under the EU Market Abuse Regulation follows.
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Cathy Turner |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status |
Director |
|
|
b) |
Initial notification/Amendment |
Initial Notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Spectris plc |
|
|
b) |
LEI |
213800Z4CO2CZO3M3T10 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) e ach type of instrument; (ii) each type of transaction; (iii) each date ; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 5p each
|
|
|
b) |
Nature of the transaction |
Spectris plc received notification on 21 February 2020 that Cathy Turner, Non-executive Director, had purchased 2,342 ordinary shares of 5p each in Spectris plc on 21 February 2020. |
|
|
c) |
Price(s) and volume(s) |
Price |
Volume(s) |
|
£29.88 |
2,342 |
||
|
d) |
Aggregated information |
Aggregated Volume |
2,342 |
|
Price |
£29.88 |
||
|
e) |
Date of the transaction |
21 February 2020 |
|
|
f) |
Place of the transaction |
London Stock Exchange: LON
|
|
Name of contact and telephone number for queries:
Rebecca Dunn
Deputy Company Secretary
01784 470 470
For and on behalf of Spectris plc
Date: 21 February 2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
